Rationale: Shared symptoms and genetic architecture between coronavirus disease (COVID-19)
and lung fibrosis suggest severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…

Background Immunocompromised patients may be at higher risk of mortality if hospitalised
with Coronavirus Disease 2019 (COVID-19) compared with immunocompetent patients. …

Background Sleep disturbance is common following hospital admission both for COVID-19
and other causes. The clinical associations of this for recovery after hospital admission are …

Background It is unclear what effect the pattern of health-care use before admission to hospital
with COVID-19 (index admission) has on the long-term outcomes for patients. We sought …

To date, there have been> 750 million reported cases of COVID-19 globally since the pandemic
began in early 2020. 1 In the UK, there have been> 1 million patients hospitalized and …

PHOSP-COVID is a national UK multi-centre cohort study of patients who were hospitalised
for COVID-19 and subsequently discharged. PHOSP-COVID was established to investigate …

Background Patients with cancer are at greater risk of dying from COVID-19 than many other
patient groups. However, how this risk evolved during the pandemic remains unclear. We …

Objective Endocrine systems are disrupted in acute illness, and symptoms reported following
coronavirus disease 2019 (COVID‐19) are similar to those found with clinical hormone …

Background In patients with COVID-19 requiring supplemental oxygen, dexamethasone
reduces acute severity and improves survival, but longer-term effects are unknown. We …

Background Sleep disturbance is common following hospitalisation both for COVID-19 and
other causes. The clinical associations are poorly understood, despite it altering …